4.8 Review

Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine

期刊

ACS NANO
卷 17, 期 9, 页码 7979-8003

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.3c00891

关键词

photomedicine; cancer; photodynamic therapy; PDT; photothermal therapy; PTT; combination therapies; multimodal nanoparticles; drug delivery; theranostics

向作者/读者索取更多资源

Tumoricidal photodynamic (PDT) and photo-thermal (PTT) therapies use light to eliminate cancer cells with precision. The combination of PDT and PTT shows potential due to their different mechanisms of action. Recent developments in multimodal nanoparticles further enhance their efficacy. This review discusses the limitations of each modality alone and how combining them can improve treatment efficacy and safety. It also analyzes the design strategies of dual PDT/PTT nanoparticles and the impact of treatment sequence and dose on treatment response. Additionally, it provides guidelines to elucidate the mechanisms underlying PDT/PTT interactions.
Tumoricidal photodynamic (PDT) and photo -thermal (PTT) therapies harness light to eliminate cancer cells with spatiotemporal precision by either generating reactive oxygen species or increasing temperature. Great strides have been made in understanding biological effects of PDT and PTT at the cellular, vascular and tumor microenvironmental levels, as well as translating both modalities in the clinic. Emerging evidence suggests that PDT and PTT may synergize due to their different mechanisms of action, and their nonoverlapping toxicity profiles make such combination potentially efficacious. Moreover, PDT/PTT combinations have gained momentum in recent years due to the development of multimodal nanoplat-forms that simultaneously incorporate photodynamically-and photothermally active agents. In this review, we discuss how combining PDT and PTT can address the limitations of each modality alone and enhance treatment safety and efficacy. We provide an overview of recent literature featuring dual PDT/ PTT nanoparticles and analyze the strengths and limitations of various nanoparticle design strategies. We also detail how treatment sequence and dose may affect cellular states, tumor pathophysiology and drug delivery, ultimately shaping the treatment response. Lastly, we analyze common experimental design pitfalls that complicate preclinical assessment of PDT/ PTT combinations and propose rational guidelines to elucidate the mechanisms underlying PDT/PTT interactions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据